Dementia in other diseases classified elsewhere, unspecified severity, with psychotic disturbance
ICD-10 F02.82 is a billable code used to indicate a diagnosis of dementia in other diseases classified elsewhere, unspecified severity, with psychotic disturbance.
F02.82 refers to dementia that occurs as a result of other diseases not specifically classified under dementia categories, characterized by unspecified severity and the presence of psychotic disturbances such as hallucinations or delusions. This code is often used when dementia is secondary to conditions like Parkinson's disease, Huntington's disease, or other neurodegenerative disorders. Patients may exhibit cognitive impairments affecting memory, reasoning, and judgment, alongside behavioral symptoms that can include agitation, aggression, and mood swings. The psychotic disturbances complicate the clinical picture, requiring careful assessment and management. Accurate coding is essential for appropriate treatment planning and resource allocation, as well as for understanding the broader implications of dementia in the context of other underlying health issues.
Detailed neurological assessments, cognitive testing results, and documentation of psychotic symptoms.
Patients with Parkinson's disease presenting with cognitive decline and hallucinations.
Neurologists must ensure that the underlying disease is clearly documented to support the use of F02.82.
Psychiatric evaluations, including mental status examinations and assessments of psychotic symptoms.
Patients with dementia exhibiting severe behavioral disturbances requiring psychiatric intervention.
Psychiatrists should document the impact of psychotic symptoms on the patient's daily functioning.
Used to assess cognitive function in patients with suspected dementia.
Results of cognitive assessments must be documented.
Neurologists and psychologists should collaborate on documentation.
Coding F02.82 is crucial for accurately reflecting the patient's condition, ensuring appropriate treatment and resource allocation, and facilitating research on dementia in the context of other diseases.
